All Genzyme articles
-
Business
AstraZeneca sells off drugs to streamline portfolio
Crohn’s disease and rare thyroid cancer drugs lie outside firm’s renewed strategic focus
-
Crohn’s disease and rare thyroid cancer drugs lie outside firm’s renewed strategic focus